Trial Profile
A Randomized, Double-blind, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Systemic Exposure and Efficacy of PAC-14028 in Children With Mild to Moderate Pediatric Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Atopic dermatitis
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors AmorePacific
- 18 Nov 2018 Status changed from active, no longer recruiting to completed.
- 02 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 02 Jul 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2018.